ROBERT F FRIEL Insider Trading
Get free email notifications about insider trading for ROBERT F FRIEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT F FRIEL. ROBERT F FRIEL is a Chairman and CEO in PERKINELMER INC ($PKI) and a Chief Financial Officer in PERKINELMER INC ($PKI) and an Executive VP & CFO in PERKINELMER INC ($PKI) and a President and CEO in PERKINELMER INC ($PKI) and a Vice Chairman in PERKINELMER INC ($PKI) and a in WEST PHARMACEUTICAL SERVICES INC ($WST) and a Director in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and a Director in NUVASIVE INC ($NUVA) and a Director in CAREFUSION Corp ($CFN) and a Director in Xylem Inc. ($XYL).
Address: 45 WILLIAM STREET WELLESLEY 02481 MA
Companies in which ROBERT F FRIEL is an Insider
CAREFUSION Corp
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT F FRIEL: Director
Holdings: 0 shares
Latest Transaction: Mar 19 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MILLENNIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT F FRIEL: Director
Holdings: 0 shares
Latest Transaction: May 15 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NUVASIVE INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT F FRIEL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 29 2020
$NUVA Market Capitalization: $3.59B
$NUVA Previous Close: $71.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PERKINELMER INC
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ROBERT F FRIEL: Chairman and CEO, President and CEO, Vice Chairman, Executive VP & CFO, Chief Financial Officer
Holdings: 570,662 shares
Current Value: $30,068,181
Latest Transaction: Feb 14 2019
$PKI Market Capitalization: $5.86B
$PKI Previous Close: $52.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WEST PHARMACEUTICAL SERVICES INC
Industry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of ROBERT F FRIEL:
Holdings: 1,799 shares
Current Value: $154,102
Latest Transaction: May 06 2021
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xylem Inc.
Industry: PUMPS & PUMPING EQUIPMENT [3561]
Position of ROBERT F FRIEL: Director
Holdings: 26,735 shares
Current Value: $1,261,357
Latest Transaction: May 13 2021
$XYL Market Capitalization: $8.48B
$XYL Previous Close: $47.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT F FRIEL
Sentiment: All, CFN, MLNM, NUVA, PKI, WST, XYL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 1,925 | 0 | 26,735 | 24.8 K to 26.7 K (+7.76 %) |
| May 06 2021 | WST | WEST PHARMACEUTICA ... | FRIEL ROBERT F | Grant | A | 0.00 | 577 | 0 | 1,799 | 1.2 K to 1.8 K (+47.22 %) | |
| May 29 2020 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 3,095 | 0 | 3,095 | |
| May 14 2020 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 3,737 | 0 | 24,596 | 20.9 K to 24.6 K (+17.92 %) |
| May 07 2020 | WST | WEST PHARMACEUTICA ... | FRIEL ROBERT F | Grant | A | 0.00 | 975 | 0 | 1,219 | 244 to 1.2 K (+399.59 %) | |
| Feb 20 2020 | WST | WEST PHARMACEUTICA ... | FRIEL ROBERT F | Grant | A | 0.00 | 244 | 0 | 244 | 0 to 244 | |
| May 17 2019 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 1,831 | 0 | 20,718 | 18.9 K to 20.7 K (+9.69 %) |